Combination buprenorphine and psychotherapy linked to highest remission rates in opioid dependence patients
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider combination buprenorphine and psychotherapy for highest remission in opioid dependence, noting observational study limits.
This retrospective cohort study evaluated 18,047 adults aged 18–45 with a diagnosis of opioid dependence across 112 U.S. health systems. The analysis compared outcomes for patients receiving no treatment, buprenorphine alone, methadone alone, psychotherapy alone, or combination therapies over a 12-month follow-up period.
The study found that buprenorphine alone was independently associated with significantly higher remission compared to no treatment, with an adjusted hazard ratio of 2.33 (95% CI: 1.85–2.94). Methadone alone also showed a significant association with remission, with an adjusted hazard ratio of 2.50 (95% CI: 2.05–3.04).
Psychotherapy duration mattered, with 30-minute sessions associated with an adjusted hazard ratio of 2.18 and 45-minute sessions with an adjusted hazard ratio of 2.38. The combination of buprenorphine and psychotherapy yielded the strongest effect, with an adjusted hazard ratio of 5.26 (95% CI: 2.68–10.32). Gabapentinoid prescriptions were positively associated with remission, while benzodiazepine co-prescription was negatively associated.
Safety data, adverse events, and tolerability were not reported. Limitations include the observational design, which prevents causal inference. These findings support policies promoting equitable access to both medication for opioid use disorder and behavioral health supports across diverse health systems.
More on Opioid Use Disorder
Lifetime opioid overdose reported by 55% of pregnant individuals with OUD in buprenorphine treatment study
What puts pregnant women with opioid addiction at highest risk for overdose?
A descriptive analysis of baseline data from a multisite RCT of 140 pregnant individuals with OUD receiving buprenorphine found 55% reported…
Pregnant women in opioid treatment face high overdose risk if they have used heroin, experienced trauma, or rely on others for money.
tDCS shows craving reduction in male methadone patients; machine learning algorithm achieves 94% diagnostic accuracy
Small study tests brain stimulation and AI for opioid addiction in men
A small RCT in 36 male methadone maintenance patients and 24 healthy controls found that active tDCS groups showed significant craving reduc…
A machine learning algorithm identified opioid addiction with 94.3% accuracy in a small study, and brain stimulation reduced cravings in men…
Telemedicine-Assisted Buprenorphine Induction Non-Inferior to Standard Care for OUD Retention
Can starting addiction treatment by video work as well as in-person visits?
A randomized controlled non-inferiority trial in 138 adults with opioid use disorder in India found telemedicine-assisted buprenorphine indu…
Patients starting opioid addiction treatment via video calls stay in care just as well as those with in-person visits during the first week.
Intraoperative methadone alters 72-hour postoperative morphine use after hip fracture surgery in older adults
Can a single dose of methadone during hip surgery reduce painkiller needs?
In this randomized trial of 129 patients aged 60 or older undergoing hip fracture surgery, a single intraoperative dose of methadone (0.10 m…
A single methadone dose during hip surgery cuts early morphine use but keeps older patients in the hospital longer than those given a placeb…
View Original Abstract ↓
BackgroundHarm reduction strategies for opioid use disorder (OUD) emphasize pragmatic, evidence-based approaches that reduce overdose risk, relapse, and other adverse outcomes without requiring abstinence. Medication for opioid use disorder (MOUD) and structured psychotherapy represent core harm-reduction modalities, yet their real-world comparative effectiveness, alone and in combination, remains underexplored at scale.MethodsA retrospective cohort study was conducted using the TriNetX Research Network, comprising de-identified electronic health records from 112 U.S. health systems. 18,047 adults aged 18–45 were identified with a diagnosis of opioid dependence (ICD-10 F11.20) between 2016 and 2025. Subjects were assigned to eight mutually exclusive treatment cohorts: no treatment (Cohort 1); buprenorphine alone (Cohort 2); methadone alone (Cohort 3); psychotherapy alone (30 minutes (Cohort 4), 45 minutes (Cohort 5), or 60 minutes (Cohort 6)); buprenorphine + psychotherapy (Cohort 7); and methadone + psychotherapy (Cohort 8), with combination treatments defined within a ±30-day window. Cox proportional hazards models estimated adjusted hazard ratios (aHRs) for remission (F11.21, F11.11) within 12 months.ResultsBuprenorphine (aHR = 2.33; 95% CI: 1.85–2.94), methadone (aHR = 2.50; 95% CI: 2.05–3.04), and psychotherapy (30 min: aHR = 2.18; 45 min: aHR = 2.38) were each independently associated with significantly higher remission compared to no treatment. The combination of buprenorphine + psychotherapy yielded the strongest effect (aHR = 5.26; 95% CI: 2.68–10.32). Anxiety diagnoses and gabapentinoid prescriptions were positively associated with remission; benzodiazepine co-prescription was negatively associated.ConclusionsIn this first national-scale, multi–health-care-organization analysis, both pharmacologic and psychosocial harm-reduction interventions were independently associated with improved OUD remission, with additive benefit when integrated. These findings underscore the value of embedding comprehensive, multimodal harm-reduction services within routine care and support policies promoting equitable access to both MOUD and behavioral health supports across diverse health systems.
PETRUSHKA decision-support tool reduced treatment discontinuation and improved symptoms in major depressive disorder
The Algorithm That Helps Doctors Pick the Right Antidepressant for You
Related in Psychiatry
Text-message CBT treatment reduced generalized anxiety disorder symptoms in young adults compared to wait-list control.
Text Message Therapy Reduces Anxiety Symptoms in Young Adults
This randomized clinical trial enrolled 103 young adults with generalized anxiety disorder or major depressive disorder. Participants receiv…
A text message treatment for depression also significantly lowered anxiety symptoms in young adults compared to waiting for care.
Cariprazine showed modest weight reduction versus aripiprazole in schizophrenia patients previously treated with olanzapine.
Cariprazine shows modest weight benefit over aripiprazole in schizophrenia patients
This trial compared cariprazine to aripiprazole in patients with schizophrenia who had previously used olanzapine. While both groups improve…
A trial found cariprazine linked to slightly more weight loss than aripiprazole in people with schizophrenia, though overall differences wer…
Self-help mindfulness and CBT interventions reduce depression and anxiety in distressed students
Mindfulness Apps Help Students Reduce Depression and Anxiety Symptoms
This RCT in 335 distressed university students in China found that self-help mindfulness interventions, with or without CBT, significantly r…
A trial found that online mindfulness programs significantly reduced depression and anxiety symptoms in stressed university students compare…
Values affirmation writing reduced anxiety in first-year minoritized STEM students compared to neutral writing in an RCT.
Writing Exercise Eases Anxiety in Minority STEM Students
This randomized controlled trial enrolled 69 first-year students from minoritized racial and ethnic backgrounds in STEM fields. Participants…
A brief writing exercise helped reduce anxiety and boost belonging among first-year STEM students from minoritized backgrounds.
From Other Specialties
Fasting plasma glucose shows higher diagnostic accuracy than HbA1c for undiagnosed diabetes in adults
Fasting glucose outperforms HbA1c for Type 2 Diabetes diagnosis in adults
This systematic review and meta-analysis evaluated diagnostic performance in 276,203 adults without previously diagnosed diabetes. Fasting p…
A massive analysis of over 276,000 adults suggests fasting glucose is a more reliable diagnostic marker than HbA1c for Type 2 Diabetes.
Meta-analysis shows active surveillance and ablative therapy for small renal masses have comparable cancer-specific survival
Active surveillance vs ablation for small kidney tumors: what works?
This systematic review and meta-analysis evaluates active surveillance (AS) versus ablative therapy (AT) for patients with small renal masse…
For small kidney tumors, ablation may boost survival, but cancer-specific death risk is similarly low with either approach.
Team-based care with rheumatological specialist assistants improved patient satisfaction in seropositive rheumatoid arthritis flares
Team-based care boosts satisfaction for rheumatoid arthritis patients
This randomized controlled trial enrolled 224 patients with seropositive rheumatoid arthritis during flares across a multicenter setting. Th…
Rheumatoid arthritis patients were more satisfied with care from a team led by specialist assistants than with standard rheumatologist visit…
Individualized intervention plans improved stress management and pain management in African American lupus patients compared to usual care.
Individualized plans may help African American lupus patients manage stress and pain
This randomized controlled trial evaluated individualized intervention plans versus a standardized chronic disease self-management program o…
A trial suggests personalized self-management options improved stress management and pain handling for African American lupus patients compa…